Results 71 to 80 of about 12,179 (241)

Clinical effectiveness of hymenoptera venom immunotherapy [PDF]

open access: yes, 2013
Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters with the frequency of VIT failure during ...
Aberer, Werner   +21 more
core   +1 more source

Implementing PEN‐FAST for penicillin allergy delabeling in a high‐prevalence population

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Self‐reported penicillin allergies lead to the use of broad‐spectrum antibiotics, increase drug resistance, and constitute an economic burden. The PEN‐FAST score aims to identify low‐risk patients for direct drug provocation tests (DPT) without prior skin testing with a reported negative predictive value (NPV) of over ...
Deniz Göcebe   +4 more
wiley   +1 more source

Diagnosing Systemic Mastocytosis: State of the Art

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT With the advent of effective multikinase and selective tyrosine kinase inhibitors in systemic mastocytosis, diagnosing this rare disease has been critical to improving patient morbidity and mortality. This state‐of‐the‐art review interprets the international diagnostic criteria, including differences between the WHO 5th edition classification ...
Anton Rets, Tracy I. George
wiley   +1 more source

Dermatoscopy in diagnosing maculopapular cutaneous mastocytosis [PDF]

open access: yesPraxis Medica, 2016
The diagnosis of cutaneous mastocytosis is based on the clinical finding of the pigmented macules or papules, positive Darier's sign and a dermal infiltrate composed of mast cells that can be better visualized by the use of special stains (Giemsa or ...
Popadić Mirjana
doaj   +1 more source

Adult onset of xanthelasmoid mastocytosis: Report of a rare entity

open access: yesIndian Journal of Dermatology, 2016
Xanthelasmoid or pseudoxanthomatous mastocytosis is an extremely rare variant of diffuse cutaneous mastocytosis. Herein, we describe an adult male with cutaneous mastocytosis showing multiple widespread yellowish ovoid papules like eruptive xanthoma.
Nafiseh Sadat Nabavi   +4 more
doaj   +1 more source

Mastocytosis: Fertility and Pregnancy Management in a Rare Disease

open access: yesFrontiers in Oncology, 2022
Mastocytosis encompasses a subset of rare diseases, characterized by the presence and accumulation of abnormal neoplastic MC in various organ systems, including skin, bone marrow, spleen and gastrointestinal tract.
Jacqueline Ferrari   +5 more
doaj   +1 more source

Next Generation Sequencing of Genes With Epigenetic Alterations in Mastocytosis

open access: yesClinical and Translational Allergy, Volume 15, Issue 10, October 2025.
ABSTRACT Aim Mastocytosis is a neoplastic disease of the bone marrow associated with the risk of frequent and severe allergic reactions. However, the genetic predisposition is not fully understood, and the crucial element in pathogenesis is the presence of the oncogenic KIT p. D816 V gene mutation.
Aleksandra Górska   +5 more
wiley   +1 more source

Bullous mastocytosis

open access: yesIndian Journal of Dermatology, 2007
Mastocytosis is a condition characterized by the disorderly infiltration of mast cells in several tissues and comprises many different clinical situations varying from indolent cutaneous forms to malignant and systemic conditions. Bullous mastocytosis is
Nayak Surajit   +3 more
doaj  

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia

open access: yesCase Reports in Medicine, 2014
Mastocytosis is a myeloproliferative neoplasm characterized by clonal expansion of abnormal mast cells, ranging from the cutaneous forms of the disease to mast cell leukemia.
Theodoros Iliakis   +13 more
doaj   +1 more source

Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosis [PDF]

open access: yes, 2017
Objectives: Systemic mastocytosis (SM) is a myeloproliferative disease characterized by the accumulation of aberrant mast cells. Since advanced subtypes of SM can lead to organ dysfunction and shortened survival, timely recognition of progressive disease
Daele, P.L.A. (Paul) van   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy